Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Di Fiore

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
The p38-mediated rapid down-regulation of cell surface gp130 expression impairs interleukin-6 signaling in the synovial fluid of juvenile idiopathic arthritis patientsNora Honke, Kim Ohl, Anastasia Wiener, et al.
BMC Cancer|June 26, 2009
Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancerHannah Jörissen, Nuran Bektas, Edgar Dahl, et al.
Oncotargets and Therapy|July 26, 2017
Comparison of a mouse and a novel human scFv-SNAP-auristatin F drug conjugate with potent activity against EGFR-overexpressing human solid tumor cellsMira Woitok, Diana Klose, Stefano Di Fiore, et al.
Frontiers in Toxicology|May 6, 2022
Application of the Adverse Outcome Pathway Concept to <i>In Vitro</i> Nephrotoxicity Assessment: Kidney Injury due to Receptor-Mediated Endocytosis and Lysosomal Overload as a Case StudySebastian Jarzina, Stefano Di Fiore, Bernhard Ellinger, et al.
Bioconjugate Chemistry|October 6, 2018
Simultaneous and Independent Dual Site-Specific Self-Labeling of Recombinant AntibodiesCarolin Wollschlaeger, Ivo Meinhold-Heerlein, Xiaojing Cong, et al.
Soft Matter|March 22, 2014
pH-dependent nano-capturing of tartaric acid using dendrimersOana G Schramm, Xaviera López-Cortés, Leonardo S Santos, et al.
Molecular Cancer Therapeutics|July 2, 2014
EpCAM-selective elimination of carcinoma cells by a novel MAP-based cytolytic fusion proteinDmitrij Hristodorov, Manal Amoury, Radoslav Mladenov, et al.
Cancer Letters|January 26, 2016
Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor modelManal Amoury, Katharina Kolberg, Anh-Tuan Pham, et al.
Pharmaceutical Research|January 12, 2017
Detection and Specific Elimination of EGFR<sup>+</sup> Ovarian Cancer Cells Using a Near Infrared Photoimmunotheranostic ApproachDirk Bauerschlag, Ivo Meinhold-Heerlein, Nicolai Maass, et al.
Oncotarget|July 25, 2016
Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demandManal Amoury, Dirk Bauerschlag, Felix Zeppernick, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
The p38-mediated rapid down-regulation of cell surface gp130 expression impairs interleukin-6 signaling in the synovial fluid of juvenile idiopathic arthritis patientsNora Honke, Kim Ohl, Anastasia Wiener, et al.
BMC Cancer|June 26, 2009
Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancerHannah Jörissen, Nuran Bektas, Edgar Dahl, et al.
Oncotargets and Therapy|July 26, 2017
Comparison of a mouse and a novel human scFv-SNAP-auristatin F drug conjugate with potent activity against EGFR-overexpressing human solid tumor cellsMira Woitok, Diana Klose, Stefano Di Fiore, et al.
Frontiers in Toxicology|May 6, 2022
Application of the Adverse Outcome Pathway Concept to <i>In Vitro</i> Nephrotoxicity Assessment: Kidney Injury due to Receptor-Mediated Endocytosis and Lysosomal Overload as a Case StudySebastian Jarzina, Stefano Di Fiore, Bernhard Ellinger, et al.
Bioconjugate Chemistry|October 6, 2018
Simultaneous and Independent Dual Site-Specific Self-Labeling of Recombinant AntibodiesCarolin Wollschlaeger, Ivo Meinhold-Heerlein, Xiaojing Cong, et al.
Soft Matter|March 22, 2014
pH-dependent nano-capturing of tartaric acid using dendrimersOana G Schramm, Xaviera López-Cortés, Leonardo S Santos, et al.
Molecular Cancer Therapeutics|July 2, 2014
EpCAM-selective elimination of carcinoma cells by a novel MAP-based cytolytic fusion proteinDmitrij Hristodorov, Manal Amoury, Radoslav Mladenov, et al.
Cancer Letters|January 26, 2016
Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor modelManal Amoury, Katharina Kolberg, Anh-Tuan Pham, et al.
Pharmaceutical Research|January 12, 2017
Detection and Specific Elimination of EGFR<sup>+</sup> Ovarian Cancer Cells Using a Near Infrared Photoimmunotheranostic ApproachDirk Bauerschlag, Ivo Meinhold-Heerlein, Nicolai Maass, et al.
Oncotarget|July 25, 2016
Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demandManal Amoury, Dirk Bauerschlag, Felix Zeppernick, et al.
Pageof 3